Immediate Impact
3 from Science/Nature 62 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis
2024 Standout
Works of Jin Zhou being referenced
A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC
2023
Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jin Zhou | 458 | 204 | 112 | 179 | 42 | 819 | |
| Anitha Shenoy | 533 | 268 | 97 | 194 | 42 | 912 | |
| Zhenhua Lin | 430 | 211 | 100 | 174 | 54 | 778 | |
| Giorgia Mandili | 475 | 198 | 93 | 143 | 40 | 963 | |
| Xiaocong Pang | 491 | 163 | 145 | 218 | 43 | 829 | |
| Liwei Lang | 541 | 169 | 78 | 194 | 52 | 896 | |
| Bingyi Lin | 429 | 187 | 158 | 172 | 46 | 850 | |
| Lang‐Ming Chi | 507 | 170 | 66 | 174 | 33 | 861 | |
| Ting Huang | 396 | 174 | 125 | 247 | 40 | 825 | |
| Fei Yue | 635 | 223 | 101 | 136 | 32 | 948 | |
| Jie Zhu | 532 | 153 | 157 | 262 | 52 | 895 |
All Works
Login with ORCID to disown or claim papers
Loading papers...